APO Research
Talk to an analyst

APO RESEARCH · REPORT

3 Phosphoinositide Dependent Protein Kinase 1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global 3 Phosphoinositide Dependent Protein Kinase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025174 pages

Choose your research edition.

Industry Research3 Phosphoinositide Dependent Protein Kinase 1 Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global 3 Phosphoinositide Dependent Protein Kinase 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 3 Phosphoinositide Dependent Protein Kinase 1 include Tolero Pharmaceuticals, Inc., Sunesis Pharmaceuticals, Inc. and Arno Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 3 Phosphoinositide Dependent Protein Kinase 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 3 Phosphoinositide Dependent Protein Kinase 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 3 Phosphoinositide Dependent Protein Kinase 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 3 Phosphoinositide Dependent Protein Kinase 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Company

Tolero Pharmaceuticals, Inc.

Sunesis Pharmaceuticals, Inc.

Arno Therapeutics, Inc.

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Type

SNS-229

PHT-427

HCI-1708

AR-12

Others

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Application

Clinic

Hospital

Others

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3 Phosphoinositide Dependent Protein Kinase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 3 Phosphoinositide Dependent Protein Kinase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3 Phosphoinositide Dependent Protein Kinase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 3 Phosphoinositide Dependent Protein Kinase 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 3 Phosphoinositide Dependent Protein Kinase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of 3 Phosphoinositide Dependent Protein Kinase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of 3 Phosphoinositide Dependent Protein Kinase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Trends Table 2. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Drivers Table 3. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Opportunities and Challenges Table 4. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Restraints Table 5. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Manufacturers Table 9. Global 3 Phosphoinositide Dependent Protein Kinase 1 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global 3 Phosphoinositide Dependent Protein Kinase 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global 3 Phosphoinositide Dependent Protein Kinase 1 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global 3 Phosphoinositide Dependent Protein Kinase 1 Manufacturers, Product Type & Application Table 13. Global 3 Phosphoinositide Dependent Protein Kinase 1 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global 3 Phosphoinositide Dependent Protein Kinase 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of SNS-229 Table 17. Major Manufacturers of PHT-427 Table 18. Major Manufacturers of HCI-1708 Table 19. Major Manufacturers of AR-12 Table 20. Major Manufacturers of Others Table 21. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (K Units) Table 23. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2027-2032) & (K Units) Table 24. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Type (2021-2026) Table 25. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Type (2027-2032) Table 26. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Type (2021-2026) & (K Units) Table 28. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Type (2027-2032) & (K Units) Table 29. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Type (2021-2026) Table 30. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Others Table 34. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (K Units) Table 36. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2027-2032) & (K Units) Table 37. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Application (2021-2026) Table 38. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Application (2027-2032) Table 39. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Application (2021-2026) & (K Units) Table 41. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Application (2027-2032) & (K Units) Table 42. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Application (2021-2026) Table 43. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Application (2027-2032) Table 44. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2021-2026) & (K Units) Table 46. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Region (2021-2026) Table 47. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecasted Market Share by Region (2027-2032) Table 49. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 51. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2027-2032) & (K Units) Table 52. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 54. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2027-2032) & (K Units) Table 61. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Region (2021-2026) & (US$ Million) Table 63. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Region (2027-2032) & (US$ Million) Table 64. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Region (2021-2026) Table 65. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Region (2027-2032) Table 66. Tolero Pharmaceuticals, Inc. Company Information Table 67. Tolero Pharmaceuticals, Inc. Business Overview Table 68. Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio Table 70. Tolero Pharmaceuticals, Inc. Recent Development Table 71. Sunesis Pharmaceuticals, Inc. Company Information Table 72. Sunesis Pharmaceuticals, Inc. Business Overview Table 73. Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio Table 75. Sunesis Pharmaceuticals, Inc. Recent Development Table 76. Arno Therapeutics, Inc. Company Information Table 77. Arno Therapeutics, Inc. Business Overview Table 78. Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio Table 80. Arno Therapeutics, Inc. Recent Development Table 81. Key Raw Materials Table 82. Raw Materials Key Suppliers Table 83. 3 Phosphoinositide Dependent Protein Kinase 1 Distributors List Table 84. 3 Phosphoinositide Dependent Protein Kinase 1 Customers List Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. 3 Phosphoinositide Dependent Protein Kinase 1 Product Image Figure 2. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales (2021-2032) & (K Units) Figure 5. Global 3 Phosphoinositide Dependent Protein Kinase 1 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 3 Phosphoinositide Dependent Protein Kinase 1 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. SNS-229 Image Figure 9. PHT-427 Image Figure 10. HCI-1708 Image Figure 11. AR-12 Image Figure 12. Others Image Figure 13. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Type (2021-2032) Figure 16. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Others Image Figure 22. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Application (2021-2032) Figure 25. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Application (2021-2032) Figure 28. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2032) Figure 30. U.S. 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2032) Figure 35. Germany 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2032) Figure 42. China 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2032) Figure 50. Brazil 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile 3 Phosphoinositide Dependent Protein Kinase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (2021-2032) & (US$ Million) Figure 61. North America 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (2021-2032) & (US$ Million) Figure 63. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. 3 Phosphoinositide Dependent Protein Kinase 1 Value Chain Figure 69. Manufacturing Cost Structure Figure 70. 3 Phosphoinositide Dependent Protein Kinase 1 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • SNS-229
  • PHT-427
  • HCI-1708
  • AR-12
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Tolero Pharmaceuticals, Inc.
  • Sunesis Pharmaceuticals, Inc.
  • Arno Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Dynamics
  1. 2.1 3 Phosphoinositide Dependent Protein Kinase 1 Industry Trends
  2. 2.2 3 Phosphoinositide Dependent Protein Kinase 1 Industry Drivers
  3. 2.3 3 Phosphoinositide Dependent Protein Kinase 1 Industry Opportunities and Challenges
  4. 2.4 3 Phosphoinositide Dependent Protein Kinase 1 Industry Restraints
3 3 Phosphoinositide Dependent Protein Kinase 1 Market by Manufacturers
  1. 3.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Manufacturers (2021-2026)
  3. 3.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global 3 Phosphoinositide Dependent Protein Kinase 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 3 Phosphoinositide Dependent Protein Kinase 1 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global 3 Phosphoinositide Dependent Protein Kinase 1 Manufacturers, Product Type & Application
  7. 3.7 Global 3 Phosphoinositide Dependent Protein Kinase 1 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 3 Phosphoinositide Dependent Protein Kinase 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 3 Phosphoinositide Dependent Protein Kinase 1 Tier 1, Tier 2, and Tier 3
4 3 Phosphoinositide Dependent Protein Kinase 1 Market by Type
  1. 4.1 3 Phosphoinositide Dependent Protein Kinase 1 Type Introduction
  2. 4.1.1 SNS-229
  3. 4.1.2 PHT-427
  4. 4.1.3 HCI-1708
  5. 4.1.4 AR-12
  6. 4.1.5 Others
  7. 4.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type
  8. 4.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2032)
  10. 4.2.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Type (2021-2032)
  11. 4.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Type
  12. 4.3.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Type (2021-2032)
  14. 4.3.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Type (2021-2032)
5 3 Phosphoinositide Dependent Protein Kinase 1 Market by Application
  1. 5.1 3 Phosphoinositide Dependent Protein Kinase 1 Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application
  6. 5.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2032)
  8. 5.2.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Application (2021-2032)
  9. 5.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Application
  10. 5.3.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Application (2021-2032)
  12. 5.3.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Application (2021-2032)
6 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region
  1. 6.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2021-2032)
  3. 6.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2021-2026)
  4. 6.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Region
  1. 7.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Region
  2. 7.1.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Region (2021-2026)
  4. 7.1.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Region (2027-2032)
  5. 7.1.4 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (2021-2032)
  8. 7.2.2 North America 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (2021-2032)
  11. 7.3.2 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Tolero Pharmaceuticals, Inc.
  2. 8.1.1 Tolero Pharmaceuticals, Inc. Company Information
  3. 8.1.2 Tolero Pharmaceuticals, Inc. Business Overview
  4. 8.1.3 Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio
  6. 8.1.5 Tolero Pharmaceuticals, Inc. Recent Developments
  7. 8.2 Sunesis Pharmaceuticals, Inc.
  8. 8.2.1 Sunesis Pharmaceuticals, Inc. Company Information
  9. 8.2.2 Sunesis Pharmaceuticals, Inc. Business Overview
  10. 8.2.3 Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio
  12. 8.2.5 Sunesis Pharmaceuticals, Inc. Recent Developments
  13. 8.3 Arno Therapeutics, Inc.
  14. 8.3.1 Arno Therapeutics, Inc. Company Information
  15. 8.3.2 Arno Therapeutics, Inc. Business Overview
  16. 8.3.3 Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio
  18. 8.3.5 Arno Therapeutics, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 3 Phosphoinositide Dependent Protein Kinase 1 Value Chain Analysis
  2. 9.1.1 3 Phosphoinositide Dependent Protein Kinase 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 3 Phosphoinositide Dependent Protein Kinase 1 Production Mode & Process
  6. 9.2 3 Phosphoinositide Dependent Protein Kinase 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 3 Phosphoinositide Dependent Protein Kinase 1 Distributors
  9. 9.2.3 3 Phosphoinositide Dependent Protein Kinase 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst